Algorithms work fast
Advanced processing runs in the background while you focus on what matters. Results come back clean and ready to use.
A higher resolution for therapeutic development
We are an AI/ML leader with a mission to deliver precision therapies for every patient with fibrotic or autoimmune disease
Our platform to pinpoint the cells and pathways driving immune disease - and how they evolve over time - to empower therapeutic development
Spatial-omics meets AI/ML innovation
We make sense of vast multimodal databases to reveal the true drivers of disease invisible to prior methods
Game-changing predictive power
We forecast how disease evolves and responds to treatment before a single patient is dosed
Building medicines at every step
Every insight feeds our in-house pipeline of precision biologics for the majority of patients that current therapies leave behind
Tagline
Short heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Medium length section heading goes here
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Science/Platform
ENSIGHT is fueled by purpose-driven AI/ML tools
Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Patient-derived human data
Short subheading goes here
Lorem ipsum dolor sit, consectetur adipiscing elit. Suspendisse varius enim eros elementum tristique. Duis cursus, mi quis viverra ornare, eros interdum nulla. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum
Figure Title
Figure Title
Understand your findings
Visual dashboards show you exactly what the data means. No guessing. No confusion. Just clarity.
Move forward with confidence
Take your findings wherever they need to go. Multiple formats, seamless integration, your way.
Move forward with confidence
Take your findings wherever they need to go. Multiple formats, seamless integration, your way.
Patient-derived human data
Short subheading goes here
Our unique and proprietary database of single-cell and spatial disease datasets across inflammation and immunity.
Provides the scale and diversity of human data needed to train GenAI models capable of uncovering novel biology.
Figure Title
Pinpointing pathogenic cell types with high resolution
Short subheading goes here
Pathosignatures delivers a holistic approach to cell prioritisation, enabling more sensitive, powerful, and high-resolution identification of disease-associated cells and tissue domains.
By leveraging single-cell, spatial, and genetics data to rank pathogenic cell types and providing independent validation, it helps reduce risk and increase confidence in discovery decisions.
Diverse Datasets
Multi-modal evidence for disease-causing cells
Precision targeting of specific cells
Short subheading goes here
Discover targets beyond the reach of traditional methods. Cell 2 Target pinpoints cell-specific and combinatorial opportunities within disease-relevant tissue domains, enabling the identification of safer and more precise therapeutic molecules.
Disease Cells
Target Combination
Patient-specific domain fingerprints
Short subheading goes here
Patient Selection utilises EnsoAI domains to generate patient-specific domain fingerprints. Domain fingerprints stratifies patients into biologically meaningful subgroups to support selection of the right patients for the right therapy.
Observed patient subgroups
Prospective patient stratification
Patient-derived human data
Short subheading goes here
The EnsoAI platform extracts spatial signals from complex biological datasets to reveal how tissues evolve throughout disease progression. By integrating single-cell and spatial data, it refines cell-state resolution, uncovers functional tissue architecture, and identifies disease-specific biology. These insights power predictive simulations of tissue evolution, signalling dynamics, treatment response, and in silico perturbation experiments, enabling deeper understanding and more informed therapeutic development.
Disease Tissue
Science/Platform
ENSIGHT is a purpose-built AI/ML platform for understanding disease in 4D
Four dimensions of disease. One integrated platform.
100% human data. Zero translational guesswork.
EnsoDB is our unique and proprietary database collating vast single-cell and spatial disease datasets across inflammation and immunity. It provides the scale and diversity of human data needed to train EnsoAI models capable of uncovering novel biology.
Figure Title
Ensocell’s platform identifies patterns in the vast complexity of human biology. It leverages decades of global data creation to reveal pathways exploitable by precision medicines.
Identify cellular culprits with confidence.
PathoSignatures interrogates single-cell, spatial, and genetics data to rank pathogenic cell types and provide validation from multiple sources. This helps reduce risk and increase confidence in development decisions.
A. Multi-modal data synthesis
B. Higher resolution human data analysis
A. Interpreting vast data sets can characterize disease variants for the first time and guide drug development. These data can be genetic (e.g. Genome-Wide Association Studies, or GWAS), cellular (e.g. how cells gather in unique domain ‘fingerprints’ or how they signal to each other), or even clinical (e.g. from patients that do not respond to current therapies).
B. ENSIGHT can leverage data to identify cell types involved in disease with a new level of precision – exceeding human specialists.
B. ENSIGHT can leverage data to identify cell types involved in disease with a new level of precision – exceeding human specialists.
No target is an island.
Cell 2 Target pinpoints cell-specific and combinatorial opportunities within 3D tissue contexts relevant to disease. This enables the identification of safer and more therapeutic molecules.
Deep selectivity assessment
One Cell2Target analysis quantifies the receptors of a target cell and compares their expression to that seen in other cell types. Understanding potential interactions with other cell types helps select molecular targets that would be most appropriate for the cell type of interest.
The right therapy, matched to the right patient.
Patient Selection uses EnsoAI to stratify patients into biologically meaningful subgroups to inform both therapeutic and clinical design. Characterizing the variety in disease will be key to precision medicine evolving beyond 'one-size-fits-all' therapies.
ENSIGHT-identified patient subgroups predict disease response for clinical enrichment
Each disease subgroup (represented by patient samples on the left) is characterised by differing prevalence of cell domains and response to therapy (right diagram). The two are related. Understanding these relationships lets Ensocell enrich patient recruitment to increase the chance of clinical success.
The fourth dimension: disease over time.
The EnsoAI platform harnesses all our datasets to reveal how tissues evolve as disease progresses. These insights power predictive simulations of tissue evolution, treatment response, and in silico simulations, enabling smarter therapeutic development.
Tissue architecture
A classic histological staining of a tissue sample at a single timepoint in disease. Its right-hand side is EnsoAI-generated, demonstrating the depth and detail of ENSIGHT’s biological understanding.
Disease process prediction
Understanding extends at every stage of disease progression, as the impact of the disease on each involved cell (represented by a single dot in the plot) can be predicted in context.
About Us
What sets Ensocell apart from the rest
Our work is guided by five key values that speak to our commitment to scientific integrity, rigour and unlocking progress through teamwork.
We are scientists driven to turn insight into ground-breaking medicines.
Purpose-driven
We develop transformative new therapies for patients facing serious disease
Curiosity
We are driven by scientific curiosity and tenacity
Collaboration
We strive for excellence in exuection and achievement as one team
Honest Communication
We are committed to meaningful dialogue, empathy, and intellectual humility
Calculated Risks
We embrace bold ideas and take calculated risks
Careers
Open Positions
Join our team and help shape what’s next.
Computational Scientist (AI and Biology)
Genomics and Data Science
We are seeking a Computational Scientist to join Ensocell at the intersection of single-cell biology, spatial genomics, and AI-driven therapeutic discovery.
Full-time
Cambridge, UK
Contact
Get in touch
We're here to collaborate.
info@ensocell.com
Eddeva (Building B920)
Babraham Research Campus
Cambridge, UKCB22 3AT
Babraham Research Campus
Cambridge, UKCB22 3AT